Improving Aqueous Solubility and In Vitro Pharmacokinetic Properties of the 3-Nitroimidazo[1,2-a]pyridine Antileishmanial Pharmacophore.
Paoli-Lombardo R, Primas N, Bourgeade-Delmas S, Hutter S, Sournia-Saquet A, Boudot C, Brenot E, Castera-Ducros C, Corvaisier S, Since M, Malzert-Fréon A, Courtioux B, Valentin A, Verhaeghe P, Azas N, Rathelot P, Vanelle P.
Paoli-Lombardo R, et al. Among authors: azas n.
Pharmaceuticals (Basel). 2022 Aug 13;15(8):998. doi: 10.3390/ph15080998.
Pharmaceuticals (Basel). 2022.
PMID: 36015146
Free PMC article.